mirtazapine has been researched along with Long Sleeper Syndrome in 13 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Medical records of individuals seen in the Comprehensive Angelman Syndrome clinic were retrospectively reviewed to determine the use of mirtazapine for disordered sleep." | 7.96 | Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases. ( Carson, R; Duis, J; Hanzlik, E; Klinger, SA, 2020) |
| "This study aimed to compare the effectiveness of mirtazapine and imipramine on not only the distressing symptoms of cancer patients such as pain, nausea, vomiting, appetite loss, and sleep disturbances but also depressive and anxiety symptoms." | 5.13 | Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. ( Akbiyik, DI; Alkis, N; Cankurtaran, ES; Ozalp, E; Soygur, H; Turhan, L, 2008) |
| "Nineteen patients (12 women and 7 men), with SSRI-induced sexual dysfunction who were in remission from major depressive disorder (total Hamilton Rating Scale for Depression [HAM-D] score < or = 10), were switched to open-label mirtazapine for up to 6 weeks." | 5.09 | Mirtazapine substitution in SSRI-induced sexual dysfunction. ( Delgado, P; Gelenberg, AJ; Laukes, C; McGahuey, C; Moreno, F; Okayli, G; Zentner, L, 2000) |
| " Medical records of individuals seen in the Comprehensive Angelman Syndrome clinic were retrospectively reviewed to determine the use of mirtazapine for disordered sleep." | 3.96 | Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases. ( Carson, R; Duis, J; Hanzlik, E; Klinger, SA, 2020) |
| "Treatment with mirtazapine or placebo had no effect on cognitive and functional status as assessed by the Mini-Mental State Examination and the Katz scale, respectively." | 2.84 | Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study. ( Camargos, EF; Louzada, LL; Naves, JO; Nóbrega, OT; Quintas, JL; Scoralick, FM, 2017) |
| "Modafinil-treated participants had a milder withdrawal syndrome as measured by the Amphetamine Cessation Symptom Assessment and less sleep disturbance in comparison to mirtazapine." | 2.73 | Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. ( McGregor, C; Mitchell, A; Srisurapanont, M; White, JM; Wickes, W, 2008) |
| "Imipramine was more effective against the clusters related to core symptoms of depression: "depression and guilt", "retardation", and "melancholia", respectively." | 2.69 | Depressed in-patients respond differently to imipramine and mirtazapine. ( Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW, 1999) |
| "The latter yielded results on VMS, insomnia, circadian rhythm disorders, obstructive sleep apnea (OSA) and restless leg syndrome (RLS)." | 2.61 | Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders. ( Aricò, I; Bonanni, E; Bonsignore, M; Caretto, M; Caruso, D; Di Perri, MC; Galletta, S; Lecca, RM; Lombardi, C; Maestri, M; Miccoli, M; Palagini, L; Provini, F; Puligheddu, M; Savarese, M; Silvestri, R; Simoncini, T; Spaggiari, MC, 2019) |
| "Relative frequencies of sleep disorders were obtained for a vast panel of antidepressant drugs through an original analysis of user's drug reviews on drug rating websites." | 1.62 | Relative frequency of drug-induced sleep disorders for 32 antidepressants in a large set of Internet user reviews. ( Michel, B; Natter, J; Yokoyama, T, 2021) |
| "Mirtazapine (MTZ) is an antidepressant, which is considered to enhance noradrenergic and serotonergic neurotransmission via antagonistic action at central α2-adrenergic autoreceptors and heteroreceptors." | 1.38 | Effects of mirtazapine on sleep disturbance under neuropathic pain-like state. ( Enomoto, T; Hirayama, S; Horiuchi, H; Ikegami, D; Inada, E; Iseki, M; Nagase, H; Nakahara, K; Narita, M; Sakai, H; Suzuki, T; Torigoe, K; Yamashita, A; Yanase, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Silvestri, R | 1 |
| Aricò, I | 1 |
| Bonanni, E | 1 |
| Bonsignore, M | 1 |
| Caretto, M | 1 |
| Caruso, D | 1 |
| Di Perri, MC | 1 |
| Galletta, S | 1 |
| Lecca, RM | 1 |
| Lombardi, C | 1 |
| Maestri, M | 1 |
| Miccoli, M | 1 |
| Palagini, L | 1 |
| Provini, F | 1 |
| Puligheddu, M | 1 |
| Savarese, M | 1 |
| Spaggiari, MC | 1 |
| Simoncini, T | 1 |
| Schreiber, S | 1 |
| Pick, CG | 1 |
| Hanzlik, E | 1 |
| Klinger, SA | 1 |
| Carson, R | 1 |
| Duis, J | 1 |
| Natter, J | 1 |
| Yokoyama, T | 1 |
| Michel, B | 1 |
| Künzel, H | 1 |
| Jeong, JH | 1 |
| Bahk, WM | 1 |
| Scoralick, FM | 1 |
| Louzada, LL | 1 |
| Quintas, JL | 1 |
| Naves, JO | 1 |
| Camargos, EF | 1 |
| Nóbrega, OT | 1 |
| Enomoto, T | 1 |
| Yamashita, A | 1 |
| Torigoe, K | 1 |
| Horiuchi, H | 1 |
| Hirayama, S | 1 |
| Nakahara, K | 1 |
| Yanase, M | 1 |
| Sakai, H | 1 |
| Ikegami, D | 1 |
| Nagase, H | 1 |
| Suzuki, T | 1 |
| Iseki, M | 1 |
| Inada, E | 1 |
| Narita, M | 1 |
| Cankurtaran, ES | 1 |
| Ozalp, E | 1 |
| Soygur, H | 1 |
| Akbiyik, DI | 1 |
| Turhan, L | 1 |
| Alkis, N | 1 |
| McGregor, C | 1 |
| Srisurapanont, M | 1 |
| Mitchell, A | 1 |
| Wickes, W | 1 |
| White, JM | 1 |
| Bruijn, JA | 1 |
| Moleman, P | 1 |
| Mulder, PG | 1 |
| van den Broek, WW | 1 |
| Gelenberg, AJ | 1 |
| McGahuey, C | 1 |
| Laukes, C | 1 |
| Okayli, G | 1 |
| Moreno, F | 1 |
| Zentner, L | 1 |
| Delgado, P | 1 |
| Thase, ME | 1 |
2 reviews available for mirtazapine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Continuous Positive Airway Pressure; Depression | 2019 |
Treatment issues related to sleep and depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Humans; M | 2000 |
5 trials available for mirtazapine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study.
Topics: Actigraphy; Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Brazil; Do | 2017 |
Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
Topics: Adaptation, Psychological; Adjustment Disorders; Adrenergic alpha-Antagonists; Adult; Antidepressive | 2008 |
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
Topics: Adult; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Centra | 2008 |
Depressed in-patients respond differently to imipramine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Anxiety | 1999 |
Mirtazapine substitution in SSRI-induced sexual dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Depressive Disorder; Female; Humans; Irritable Mood; Male | 2000 |
6 other studies available for mirtazapine and Long Sleeper Syndrome
| Article | Year |
|---|---|
Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?
Topics: Analgesics; Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Disease Models, Animal; | 2020 |
Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases.
Topics: Adolescent; Angelman Syndrome; Child; Child, Preschool; Humans; Mirtazapine; Retrospective Studies; | 2020 |
Relative frequency of drug-induced sleep disorders for 32 antidepressants in a large set of Internet user reviews.
Topics: Antidepressive Agents; Humans; Internet; Mirtazapine; Reproducibility of Results; Sleep Wake Disorde | 2021 |
[Use of psychotropic drugs in patients with chronic pain].
Topics: Chronic Pain; Cortisone; Depression; Guillain-Barre Syndrome; Humans; Mianserin; Middle Aged; Mirtaz | 2014 |
Sleep-related eating disorder associated with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Feeding and Eating Disorders; Female; Humans; Mianserin; Mirtazapi | 2014 |
Effects of mirtazapine on sleep disturbance under neuropathic pain-like state.
Topics: Animals; Disease Models, Animal; Histamine H1 Antagonists; Hyperalgesia; Male; Mianserin; Mice; Mice | 2012 |